Departamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220, Madrid, Spain.
Anal Chim Acta. 2021 Oct 16;1182:338946. doi: 10.1016/j.aca.2021.338946. Epub 2021 Aug 12.
This work reports the first electrochemical bioplatform developed for the multidetection of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in DNA, DNA N6-methyladenine (6mA) and RNA N6-methyladenosine (m6A) methylations at global level. Direct competitive immunoassays were implemented on the surface of magnetic beads (MBs) and optimized for the single amperometric determination of different targets varying in length, sequence and number of methylations on screen-printed carbon electrodes. After evaluating the sensitivity and selectivity of such determinations and the confirmation of no cross-reactivity, a multiplexed disposable platform allowing the simultaneous determination of the mentioned four methylation events in only 45 min has been prepared. The multiplexed bioplatform was successfully applied to the determination of m6A in cellular total RNA and of 5-mC, 5-hmC and 6mA in genomic DNA extracted from tissues. The developed bioplatform showed its usefulness to discriminate the aggressiveness of cancerous cells and between healthy and tumor tissues of colorectal cancer patients.
本工作报道了首个电化学生物平台,用于在 DNA 中多维检测 5-甲基胞嘧啶 (5-mC) 和 5-羟甲基胞嘧啶 (5-hmC)、DNA N6-甲基腺嘌呤 (6mA) 和 RNA N6-甲基腺苷 (m6A) 甲基化。在磁性珠 (MB) 表面上实施直接竞争性免疫测定,并针对不同长度、序列和甲基化数量的不同目标在丝网印刷碳电极上进行单安培测定进行优化。在评估了这些测定的灵敏度和选择性并确认无交叉反应后,制备了一种可同时在 45 分钟内测定上述四种甲基化事件的可复用一次性平台。该复用生物平台已成功应用于细胞总 RNA 中 m6A 的测定以及组织中提取的基因组 DNA 中 5-mC、5-hmC 和 6mA 的测定。所开发的生物平台显示出区分癌细胞侵袭性以及区分结直肠癌患者健康组织和肿瘤组织的能力。